Právní předpis byl sestaven k datu 01.01.2012.
Zobrazené znění právního předpisu je účinné od 01.01.2012.
386
XXXXXXXX
xx xxx 30. xxxxxxxxx 2011,
xxxxxx xx mění xxxxxxxx x. 384/2007 Xx., x seznamu xxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxx x. 114/2009 Xx.
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxx xxxxx §39c odst. 1 xxxxxx x. 48/1997 Xx., x xxxxxxxx xxxxxxxxxx xxxxxxxxx a x změně a xxxxxxxx xxxxxxxxx souvisejících xxxxxx, xx xxxxx xxxxxx č. 261/2007 Xx. a xxxxxx x. 298/2011 Xx.:
Xx. I
Příloha x xxxxxxxx č. 384/2007 Sb., x xxxxxxx xxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxx x. 114/2009 Xx., xxx:
"Xxxxxxx x xxxxxxxx x. 384/2007 Xx.
Xxxxxx xxxxxxxxxxxx xxxxxx
Xxxxx xxxxxxxxxxxx xxxxxxx | Xxxxxxxxxxxx skupina | Číslo xxxxxxxxxx xxxxxxx | Xxxxxxxxxx xxxxxxx *) | Léčivé xxxxx v xxxxxxxxxx xxxxxxx převažující |
1 | Léčiva x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx choroby x refluxní choroby xxxxx | 1/1 | xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx xxxxxxx choroby a xxxxxxxx choroby jícnu, xxxxxxxxx - xxxxxxxxxxx X2 xxxxxxxxx | X02XX01 xxxxxxxxx, X02XX02 xxxxxxxxx, X02XX03 xxxxxxxxx |
1/2 | xxxxxx k terapii xxxxxxxxxxxxxxxx vředové xxxxxxx x xxxxxxxx xxxxxxx xxxxx, xxxxxxxxxxxx - xxxxxxxxxxx H2 receptorů | A02BA01 xxxxxxxxx, X02XX02 xxxxxxxxx, X02XX03 xxxxxxxxx | ||
1/3 | xxxxxx x xxxxxxx xxxxxxxxxxxxxxxx vředové xxxxxxx x xxxxxxxx xxxxxxx jícnu, p.o. - xxxxxxxxxx xxxxxxxxx xxxxx x xxxx xxxxxx | X02XX01 omeprazol xxx 10 xx x xxxxx tob., A02BC02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxx, X02XX04 xxxxxxxxxx, X02XX05 esomeprazol | ||
1/4 | léčiva x xxxxxxx xxxxxxxxxxxxxxxx vředové xxxxxxx x xxxxxxxx xxxxxxx jícnu, xxxxxxxxxxxx - xxxxxxxxxx xxxxxxxxx xxxxx | X02XX01 xxxxxxxxx, X02XX02 pantoprazol, A02BC05 xxxxxxxxxxx | ||
2 | Xxxxxxxxxxxx | 2/1 | xxxxxxxxxxxx, x.x. | X03XX04 xxxxxxxxx, X03XX06 xxxxxxxxx xxxxxx, X03XX02 xxxxxxxxxx, X03XX01 xxxxxxxxxxxxxxx |
3 | Xxxxxxxxxxx | 3/1 | xxxxxxxxxxx, x.x. | X03XX xxxxxxx, X03XX01 xxxxxxxxxxxxx, X03XX03 xxxxxxxxxx |
4 | Xxxxxxxxxxx | 4/1 | xxxxxxxxxxx, p.o. - xxxxxxx, x.x. | X04XX01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx, X04XX05 xxxxxxxxxxxx |
4/2 | xxxxxxxxxxx, xxxxxxx, xxxxxxxxxxxx a xxxx. aplikace - | X04XX01 xxxxxxxxxxx, X04XX02 xxxxxxxxxxx, X04XX05 palonosetron | ||
5 | Léčiva x xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx | 5/1 | xxxxxx k terapii xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx, x.x. - kyselina xxxxxxxxxxxxxxx x xx xxxxx xxxxxxx | X07XX01 xxxxxxxxxxxx, X07XX02 xxxxxxxxx |
7 | Xxxxxxxxxxxxx xxxxxxxxx | 7/1 | xxxxxxxxxxxxx xxxxxxxxx, x.x. - xxxxxxxxxxxxx xxxxxx xxxxx | X09XX02 xxxxxxxxxxxxx xxxxxxxxx - xxxxxxxxxxxxx xxxxxx xxxxx nad 20&xxxx;000 U x xxxxx xxxxxxx |
8 | Xxxxxx x xxxxxxx xxxxxxx - xxxxxxxx | 8/1 | xxxxxxxxxx xxxxxxxx xxxxxxxx, xxxxxxxxx | X10XX01 xxxxxxx xxxxxx, X10XX04 inzulin xxxxxx X10XX05 inzulin xxxxxx X10XX06 xxxxxxx glulisin |
8/2 | dlouhodobě působící xxxxxxxx | X10XX04 inzulin glargin A10AE05 xxxxxxx xxxxxxx | ||
8/3 | xxxxxxxx, xxxxxxxx | X10XX01 xxxxxxx xxxxxx X10XX04 inzulin xxxxxx X10XX05 xxxxxxx xxxxxx X10XX06 xxxxxxx glulisin | ||
9 | Léčiva k terapii xxxxxxx | 9/2 | xxxxxx x xxxxxxx xxxxxxx, x.x. - xxxxxxxx xxxxxxxxxxxx II. xxxxxxxx | X10XX07 xxxxxxxx, X10XX08 xxxxxxxxx, X10XX09 xxxxxxxxx, X10XX12 glimepirid |
9/4 | léčiva x xxxxxxx xxxxxxx, x.x. - xxxxxxx | X10XX02 repaglinid, A10BX03 xxxxxxxxxx | ||
9/5 | xxxxxx x xxxxxxx xxxxxxx, xxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxx | X10XX01 xxxxxxxxxxx, X10XX02 xxxxxxxxxxxx, X10XX03 xxxxxxxxxxx, X10XX04 xxxxxxxx, X10XX07 xxxxxxxxxx | ||
10 | Xxxxxx k terapii xxxxxxxx xxxxxxxx, p.o. | 10/1 | léčiva k xxxxxxx xxxxxxxx xxxxxxxx, x.x. - soli xxxxxxx | X12XX04 uhličitan xxxxxxxx, X12XXX7 xxxxxxx xxxxxxxx |
10/2 | xxxxxx k xxxxxxx xxxxxxxx xxxxxxxx, x.x. - xxxx xxxxxxx | X120006 xxxxxxx xxxxxxxxx, X12XX30 xxxxxx, různé xxxx x xxxxxxxxx | ||
11 | Xxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxx | 11/1 | xxxxxx x xxxxxxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxx | X16XX03 agalsidáza alfa, A16AB04 xxxxxxxxxx xxxx |
12 | Xxxxxx x xxxxxxx xxxx k profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx | 12/1 | xxxxxx x xxxxxxx xxxx x xxxxxxxxx tromboembolických xxxxxxxxxx, xxxxxxxxxxxx - xxxxxxxxxxxxxxxx xxxxxxxx - xxxxx síly určené xxxxxxxxx x xxxxxxxxx XXX | X01XX04 xxxxxxxxxx, X01XX05 enoxaparin, B01AB06 xxxxxxxxxx, X01XX08 reviparin, B01AB12 bemiparin |
12/2 | léčiva x xxxxxxx nebo x xxxxxxxxx tromboembolických onemocnění, xxxxxxxxxxxx - xxxxxxxxxxxxxxxx xxxxxxxx - xxxxx xxxx xxxxxx xxxxxxxxx x xxxxxxx TEN | B01AB04 xxxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX06 xxxxxxxxxx, X01XX08 xxxxxxxxx, X01XX12 xxxxxxxxx | ||
12/3 | xxxxxx x terapii xxxx k profylaxi xxxxxxxxxxxxxxxxx xxxxxxxxxx, parenterální - xxxxx inhibitory xxxxxxx Xx x xxxxxxxx | X01XX01 xxxxxxxxx, X01XX02 lepirudin, B01AE06 xxxxxxxxxxx | ||
13 | Xxxxxx x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx | 13/1 | xxxxxx x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx onemocnění, p.o. - antagonisté xxxxx XXX xx xxxxxxxx | X01XX04 xxxxxxxxxxx, X01XX22 xxxxxxxxx |
13/2 | xxxxxx x xxxxxxx xxxx x xxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxxx, x.x. - xxxxx xxxxxxxxxx xxxxxxx Xx x xxxxxxxx | X01XX07 dabigatran, B01AX06 xxxxxxxxxxx, X01X xxxxxxxx | ||
14 | Xxxxxxxxxx xxxxxx k xxxxxxx xxxxxx arteriální xxxxxxxxxx (XXX) | 14/2 | xxxxxxxxxx xxxxxx x xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx (XXX), p.o. | C02KX01 xxxxxxxx, X02XX02 ambrisentan |
15 | Fibrinolytika, xxxxxxxxxxxx | 15/1 | xxxxxxxxxxxxx, xxxxxxxxxxxx - xxxxxx | X01XX02 xxxxxxxxx, X01XX04 xxxxxxxxx, X01XX11 tenektepláza |
16 | Antifibrinolytika - xxxxxxxxxxxxx | 16/1 | xxxxxxxxxxxxxxxxx, x.x. - xxxxxxxxxxxxx | X02XX02 xxxxxxxx xxxxxxxxxxx, X02XX03 xxxxxxxx aminomethylbenzoová |
16/2 | antifibrinolytika, xxxxxxxxxxxx - xxxxxxxxxxxxx | X02XX02 xxxxxxxx tranexámová, B02AA03 xxxxxxxx xxxxxxxxxxxxxxxxxxx | ||
17 | Xxxxxx x xxxxxxx xxxxxx (xxxx xxxxxx) | 17/1 | xxxxxx k xxxxxxx xxxxxx, p.o. - dvoj. xxxx xxxxxxxxx xxxxxx | X03XX02 xxxxxxx xxxxxxxxx, X03XX07 síran xxxxxxxxx, X03XX02 xxxxxxx železa x xxxxxxxxxxx |
17/2 | xxxxxx x xxxxxxx xxxxxx, xxxxxxxxxxxx - xxxxxxxxx xxxxxx | X03XX02 xxxxxxx xxxxxx x xxxxxxxxxxx, X03XX07 xxxxxxxx sodno-železitý, B03AC carboxymaltosum xxxxxxxx | ||
18 | Xxxxxxx stimulující xxxxxxxxxxx xxxxxxxxx xx xxxxxxxx xxxxxxxxxxxxxx | 18/1 | xxxxxxx xxxxxxxxxxx xxxxxxxxxxx, xxxxxxxxxxxx | X03XX01 xxxxxxxxxxxxx (xxxxxxx xxxx), X03XX02 xxxxxxxxxxx xxxx, X03XX03 xxxxxxxxxx (Metoxy-polyetylenglykol -epoetin xxxx) xxxxxxx beta, xxxxxxx xxxxx, epoetin xxxx |
20 | Xxxxxxxx NO x xxxxxxx xxxxxx xxxxxxxx | 20/1 | xxxxxxxx XX x xxxxxxx xxxxxx xxxxxxxx - xxxxxxx xxxxxxxx xxxxxxxx, xxxxxxx. | X01XX02 xxxxxxxx xxxxxxxxx, X01XX08 isosorbid xxxxxxxx |
20/2 | xxxxxxxx XX x xxxxxxx xxxxxx xxxxxxxx - xxxxxxxxxx terapie, x.x. | X01XX08 xxxxxxxxx dinitrát, C01DA14 xxxxxxxxx xxxxxxxxxx, X01XX12 xxxxxxxxxx | ||
21 | Xxxxxxxxxxxxxxxx | 21/1 | xxxxxxxxxxxxxx xxxxx xxxxxxxx xxxxxxxxx i xxxxxxxxx kromě xxxxxxxxx, x.x. | X02XX05 moxonidin, C02AC06 xxxxxxxxxx, X02XX06 xxxxxxxx |
22 | Xxxxxxxxx | 22/1 | xxxxxxxxx, x.x. | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX xxxxxxxxx, X03XX04 xxxxxxxxxxxx, X03XX11 xxxxxxxxx |
23 | Xxxxxxxxxxxxxxxx (xxxx-xxxxxxxxx) | 23/1 | xxxxxxxxxxxxxxxx, beta- blokátory xxxxxxxxxxxxxxxx - xxxxxxxxxxxxx, x xxxxxxxxxx xxxxxxxx, x.x. | X07XX02 xxxxxxxxxx (neretardované xxxxxx xxxxx), X07XX03 xxxxxxxx, X07XX17 xxxxxxxxxx |
23/2 | xxxxxxxxxxxxxxxx, xxxx-xxxxxxxxx xxxxxxxxxxxxxxxx - retardované, x xxxxxxxxxx působící, x.x. | X07XX02 xxxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X07XX04 xxxxxxxx, X07XX05 xxxxxxxxx, X07XX07 xxxxxxxxxx, X07XX08 xxxxxxxxxx, X07XX12 xxxxxxxxx, X07XX02 xxxxxxxxxx | ||
24 | Xxxxxxxxxxxxxxxx - xxxxxxxxx xxxxxxxxxx xxxxxx | 24/1 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx kanálů dihydropyridinového xxxx, dlouhodobě xxxxxxxx, x.x. | X08XX01 xxxxxxxxx, X08XX02 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX03 xxxxxxxxx (xxxxxxxxxxx xxxxxx xxxxx), X08XX08 xxxxxxxxxxx, X08XX09 xxxxxxxxx, X08XX10 xxxxxxxxxx, X08XX12 barnidipin, C08CA12 lercanidipin |
24/2 | antihypertenziva, xxxxxxxxx kalciových xxxxxx xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxxxxxxxx xxxx, p.o., xxxxxxxxxxx xxxxx | X08XX01 xxxxxxxxx, X08XX01 xxxxxxxxx | ||
24/3 | xxxxxxxxxxxxxxxx, xxxxxxxxx xxxxxxxxxx kanálů xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxxxxxxxxxx xxxx, x.x., xxxxxxxxxx xxxxxxxx | X08XX01 xxxxxxxxx, X08XX01 xxxxxxxxx | ||
25 | Xxxxxxxxxxxxxxxx- xxxxxx xxxxxxxx xx xxxxxx xxxxx- xxxxxxxxxxx- xxxxxxxxxx | 25/1 | xxxxxxxxxxxxxxxx, xxxxxxxxxx ACE - xxxxxxxxxx x xxxxxxxxxxx xxxxxxxx, x.x. | X09XX01 xxxxxxxxx, X09XX02 xxxxxxxxx, X09XX06 xxxxxxxxx |
25/2 | xxxxxxxxxxxxxxxx, xxxxxxxxxx ACE xxxxxxxxxx xxxxxxxx, x.x. | X09XX03 lisinopril, C09AA04 xxxxxxxxxxx, X09XX05 xxxxxxxx, X09XX08 xxxxxxxxxx, X09XX09 xxxxxxxxxx, X09XX10 xxxxxxxxxxxx, X09XX11 spirapril, C09AA13 xxxxxxxxx, X09XX16 xxxxxxxxx | ||
25/3 | xxxxxxxxxxxxxxxx, antagonisté xxxxxxxxxxxx XX xxxxxxx, x.x. | X09XX01 xxxxxxxx, X09XX02 xxxxxxxxxx, X09XX03 xxxxxxxxx, X09XX04 xxxxxxxxxx, X09XX06 kandesartan, C09CA07 xxxxxxxxxxx, X09XX08 xxxxxxxxxx | ||
25/4 | xxxxxxxxxxxxxxxx, antagonisté xxxxxxxxxxx, x.x. | X03XX01 spironolakton, C03DA04 xxxxxxxxx | ||
26 | Xxxxxxxxx xxxxxxxxxxxxxx | 26/2 | xxxxxxxxx vazodilatancia, xxxxxxxxxxxx | X04XX02 tolazolin, C04AD etofylin, C04AD03 xxxxxxxxxxxx |
28 | Xxxxxxxxxxxxxx | 28/1 | xxxxxxxxxxxxxx, statiny, x.x. | X10XX01 xxxxxxxxxxx, X10XX02 lovastatin, C10AA03 xxxxxxxxxxx, X10XX04 xxxxxxxxxxx, X10XX05 xxxxxxxxxxxx, X10XX07 xxxxxxxxxxxx |
28/2 | xxxxxxxxxxxxxx-xxxxxxx, x.x. | X10XX02 bezafibrát, C10AB05 xxxxxxxxxx, X10XX08 xxxxxxxxxxx | ||
29 | Xxxxxxxxxxxx používaná v xxxxxxxxxxxx | 29/1 | xxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx x xxxxxxx xxxxxxx, (xxxxx xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx x tridecanamini xxxxxxxxxxx) | X01XX01 xxxxxxxx, X01XX02 xxxxxxxxx, X01XX01 xxxxxxxxxxx, X01XX03 xxxxxxxx, X01XX10 xxxxxxxxx, X01XX11 xxxxxxxxxx, X01XX16 xxxxxxxxxxx, X01XX14 ciklopirox, D01AE15 terbinafin, D01AE22 xxxxxxxx |
30 | Xxxxxxxxxxxxxx používaná x xxxxxxxxxxxx | 30/1 | xxxxxxxxxxxxxx xxxxxxxxx v xxxxxxxxxxxx x xxxxxxx xxxxxxx, xxxxx | XX5XX dehty, D05AA xxxxx (xxxxxxxxx xxxxx) |
30/2 | xxxxxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxxx k lokální xxxxxxx, xxxx léčiva xxx xxxxx | X05XX02 xxxxxxxxxxxx, XX5XX03 xxxxxxxxxx, X05XX04 xxxxxxxxxx, X05XX05 xxxxxxxxx | ||
31 | Xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx | 31/1 | xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxx | X06XX01 xxxxxxxx xxxxxxxx, X06XX13 retapamulin |
32 | Kortikosteroidy používané x xxxxxxx terapii - xxxxx a xxxxxxx silné | 32/1 | kortikosteroidy xxxxxxxxx x lokální xxxxxxx - xxxxx x xxxxxxx xxxxx 1. x 2. xxxxxxxx | X07XX19 xxxxxxxxxxxx xxxxxx (0,01%), X07XX04 xxxxxxxxxxx xxxxxxxx (0,01%), D07AA02 xxxxxxxxxxxxx acetát (1,0%), D07AA03 xxxxxxxxxxx (0,4%), X07XX09 xxxxxxxxxxxx xxxxxxxx (0,1%) D07AB19 xxxxxxxxxxxx xxxxxx 0,025%, D07AC04 xxxxxxxxxxx-xxxxxxxx 0,025% |
32/2 | xxxxxxxxxxxxxxx používané x xxxxxxx xxxxxxx - xxxxx a xxxxxxx xxxxx 3. x 4. xxxxxxxx | X07XX10 xxxxxxxxxxxxx (0,05%), X07XX08 desonid, D07AB02 hydrokortison xxxxxxx (0,1 %) | ||
33 | Kortikosteroidy xxxxxxxxx x xxxxxxx xxxxxxx - xxxxx x xxxxx xxxxx | 33/1 | xxxxxxxxxxxxxxx xxxxxxxxx k lokální xxxxxxx - xxxxx x xxxxx silné 1. a 2. xxxxxxxx | X07XX04 xxxxxxxxxxx xxxxxxxx (0,05% - 0,2%), X07XXX3 xxxxxxxxxxxxxx (0,25%) |
33/2 | xxxxxxxxxxxxxxx používané x xxxxxxx xxxxxxx - silné a xxxxx silné 3. x 4. generace | D07AC01 xxxxxxxxxxxx xxxxxxx (0,1%), X07XX01 xxxxxxxxxxxx xxxxxxxxxxx (0,05%), X07XX17 xxxxxxxxxx propionát (0,05%), X07XX12 Xxxxxxxxxxx xxxxxxxxx (0,05%), D07AD02 Xxxxxxxxxx (0,1%), X07XX01 xxxxxxxxxx xxxxxxxxx (0,05%), X07XX14 methylprednisolon xxxxxxxx (0,1 %), X07XX13 xxxxxxxxx furoát (0,1%), D07AC18 xxxxxxxxxxxx | ||
35 | Xxxxxx používaná x xxxxxxx xxxxxxx acne xxxxxxxx | 35/1 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx vulgaris - retinoidy | D10AD01 tretinoin, D10AD03 xxxxxxxx, X10XX04 xxxxxxxxxxxx |
35/2 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxx xxxxxxxx - xxxxxxx xxxxx | X10XX01 benzoyl xxxxxxx, X10XX03 xxxxxxxx xxxxxxxx | ||
35/3 | xxxxxx xxxxxxxxx x xxxxxxx terapii acne xxxxxxxx - xxxxxxxxxxxx xxxxx | X10XX01 klindamycin, D10AF02 xxxxxxxxxxxx | ||
36 | Xxxxxxxxxxxxxxx xxxxxxxxx k xxxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx | 36/1 | xxxxxxxxxxxxxxx xxxxxxxxx x lokální xxxxxxx xxxxxxxx xxxxxxxxxxx | X11XX14 xxxxxxxxxx, X11XX15 xxxxxxxxxxxx |
37 | Xxxxxxxxxxxxx xxxxxxxxxxxx | 37/1 | xxxxxxxxxxxxx xxxxxxxxxxxx, lokální nebo xxxxxxxxx xxxxxxxx | X01XX02 xxxxxxxxxxx, X01XX05 xxxxxxxx, X01XX12 xxxxxxxxxxxx |
38 | Xxxxxxxxx | 38/1 | xxxxxxxxx x xxxxxxxxxxx xxxxxxx | X03XX03 xxxxxxxxxxx, X03XX01 xxxxxxxxxx |
39 | Xxxxxxxxxxxxx xxxxxxxxxxx používaná x xxxxxxx terapii | 39/1 | gynekologická xxxxxxxxxxx, xxxxxxx nebo vaginální xxxxxxxx | X01XX02 natamycin, G01AA10 xxxxxxxxxxx, X01XX12 xxxxxxxxxx |
40 | Xxxxxxxxxxxxxx | 40/1 | xxxxxxxxxxxxxx, xxxxxxxxxxxx | X02XX01 xxxxxxxxx, X02XX04 xxxxxxxxxx |
41 | Xxxxxxxxxx xxxxxxxxxx | 41/2 | xxxxxxxxxx prolaktinu, xxxxxxxxxxxx agonisté II. xxxxxxxx | X02XX03 kabergolin, G02CB04 xxxxxxxxxx |
42 | Xxxxxxxxx | 42/1 | xxxxxxxxx, x.x. | X03XX03 estradiol, G03CA04 xxxxxxx, X03XX05 xxxxxxx |
42/2 | xxxxxxxxx, lokální xxxx xxxxxxxxx xxxxxxxx | X03XX03 xxxxxxxxx, X03XX04 xxxxxxx | ||
43 | Xxxxxxxxxx | 43/1 | xxxxxxxxxx X. xxxxxxxx, x.x. | X03XX02 medroxyprogesteron, G03DC02 norethisteron, G03DC03 xxxxxxxxxxx |
43/2 | xxxxxxxxxx XX. generace, x.0. | X03XX04 xxxxxxxxxxx, X03X1301 xxxxxxxxxxxxxxx | ||
43/3 | xxxxxxxxxx, xxxxxxxxxxxx | X03XX03 xxxxxxxxxxxxxxxxxx, X03XX04 xxxxxxxxxxx (xxxxxxx xxxxxx xxxxx) | ||
44 | Xxxxxxxxxxxxx | 44/1 | xxxxxxxxxxxxx xxxxxxxx, parenterální | G03GA01 choriový xxxxxxxxxxxx, X03XX08 rekombinantní thoriový xxxxxxxxxxxx |
44/2 | xxxxxxxxxxxxx xxxxxxx, parenterální | G03GA02 xxxxxxxxxxxx lidský, xxxxxxxxxxxx xxxxxx xxxxxx xxxxxxx, X03XX04 xxxxxxxxxxxxx, X03XX04 urofolitropin xxxxxx xxxxxxx, X03XX05 xxxxxxxxxx xxxx, X03XX06 xxxxxxxxxx xxxx, X03XX07 xxxxxxxx xxxx | ||
45 | Xxxxxx spasmolytika | 45/1 | močová xxxxxxxxxxxx, xxxxxxxxxxxxx formy, x.x. | X04XX04 xxxxxxxxxx, X04XX06 xxxxxxxxxx, X04XX07 xxxxxxxxxx, X06XX09 xxxxxxxx xxxxxxx |
45/2 | xxxxxx xxxxxxxxxxxx, xxxxxxxxxxx xxxxx, x.x. x | X04XX04 xxxxxxxxxx, X04XX07 xxxxxxxxxx, | ||
xxxxxxxxxxxxx xxxxxxxx | X04XX08 xxxxxxxxxxx, X04XX10 xxxxxxxxxxx, G04BD11 xxxxxxxxxxx | |||
46 | Xxxxxx x xxxxxxx xxxxxxx hyperplazie xxxxxxxx | 46/1 | xxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxx, xxxxxxxxxxx xxxx adrenergních xxxxxxxxx, p.o. | C02CA04 xxxxxxxxx, X04XX01 xxxxxxxxx, X04XX02 xxxxxxxxxx, X04XX03 xxxxxxxxx |
46/2 | xxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx prostaty, xxxxxxx, x.x. | X04XX01 xxxxxxxxxx, X04XX02 dutasterid, G04CX03 xxxxxxxxxxx | ||
47 | Xxxxxxxxxxx xxxxxxxxx hormonu | 47/2 | antagonisté xxxxxxxxx hormonu, xxxxxxxxxx xxxxxxxx, parenterální | HB1CB02 xxxxxxxxx, X01XX03 xxxxxxxxx |
48 | Xxxxxxxxxxx xxxxxxxxxxxx uvolňujícího xxxxxxx | 48/1 | xxxxxxxxxxx xxxxxxxxxxxx -uvolňujícího xxxxxxx, xxxxxxxxxxxx | X010001 xxxxxxxxx, X010002 xxxxxxxxxx |
49 | Xxxxxxxxxxxxxxx x xxxxxxxxx xxxxxxx | 49/1 | xxxxxxxxxxxxxxx s převažujícím xxxxxxxxxxxxxxxxx xxxxxxx, x.x. | X02XX04 xxxxxxxxxxxxxxxxx, X02XX07 xxxxxxxxx, X02XX08 xxxxxxxxxxxx |
49/2 | xxxxxxxxxxxxxxx s převažujícím xxxxxxxxxxxxxxxxx xxxxxxx, xxxxxxxxxxxx - xxxxxxx | X02XX01 xxxxxxxxxxxx (xxxxxxx xxxxxx xxxxx), X02XX04 xxxxxxxxxxxxxxxxx (xxxxxxx xxxxxx xxxxx) | ||
50 | Xxxxxxxxxxxxxxx xxxxxx | 50/1 | xxxxxxxxxxxxxxx léčiva, x.x. | X03XX02 propylthiouracil, H03BB02 xxxxxxxxx |
51 | Xxxxxxxxxxxx | 51/1 | xxxxxxxxxxxx, x.x. | X01XX02 doxycyklin, J01AA08 xxxxxxxxxx |
52 | Xxxxxxxxxx x xxxxx xxxxxxxx | 52/1 | xxxxxxxxxx s úzkým xxxxxxxx, x.x. | X01XX02 xxxxxxxxxxxxxxxxxxxxx, X01XX06 xxxxxxxxxxx, X01XX10 xxxxxxxxx xxxxxxxxxxxxxxxxxxxxx |
53 | Xxxxxxxxxxxxx | 53/1 | xxxxxxxxxxxxx X. generace, p.o. | J01DB01 xxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX04 cefaklor |
53/2 | cefalosporiny xX. generace, x.x. | X01XX02 xxxxxxxxx axetil, J01DC10 xxxxxxxxx | ||
53/3 | xxxxxxxxxxxxx X. xxxxxxxx, xxxxxxxxxxxx | X01XX03 xxxxxxxxx, X01XX04 cefazolin | ||
53/4 | cefalosporiny XXX. xxxxxxxx (kromě xxxxxxxxxxxx), xxxxxxxxxxxx | X01XX01 cefotaxim, J01DD04 xxxxxxxxxx | ||
54 | Xxxxxxxxxxx | 54/1 | xxxxxxxxxxx, xxxxxx, | X01XX02 meropenem, J01DH04 xxxxxxxxx, X01XX51 xxxxxxxx a enzymový xxxxxxxxx |
55 | Xxxxxxxxxxx, azalidová, xxxxxxxxxx x linkosamidová antibiotika | 55/1 | makrolidy, x.x. | X01XX01 erythromycin, J01FA02 xxxxxxxxxx, X01XX06 xxxxxxxxxxxxx, X01XX09 klarithromycin, J01FA10 xxxxxxxxxxxx |
55/2 | xxxxxxxxxxx, x.x. | X01XX01 xxxxxxxxxxx, X01XX02 linkomycin | ||
56 | Chinolony | 56/1 | chinolony, x.x. (xxxxx xxxxxxxxxxxxx x xxxxxxxxxxxx) | X01XX01 xxxxxxxxx, X01XX02 xxxxxxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX12 xxxxxxxxxxxx |
57 | Xxxxxxxxxxx xxxxxxxx | 57/1 | xxxxxxxxxxx xxxxxxxx, p.o. | J01XD01 xxxxxxxxxxxx, X01XX03 xxxxxxxxx |
58 | Xxxxxxxxxxxx k xxxxxxxxx xxxxxxx | 58/1 | xxxxxxxxxxxx x xxxxxxxxx xxxxxxx, x.x. - xxxxxxxxxx xxxxxxxx | X02XX03 vorikonazol, J02AC04 xxxxxxxxxxx |
59 | Xxxxxxxxx xxxxxxxxxxxx proti xxxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxx | 59/1 | xxxxxxxxx antivirotika xxxxx xxxxxxxx vyvolaným xxxxxxxxxxx xxxxxxx, p.o. | J05AB01 xxxxxxxxx, X05XX09 xxxxxxxxxxx, X05XX11 xxxxxxxxxxxx, X05XX15 brivudin |
60 | Antiretrovirotika | 60/2 | antiretrovirotika xxxxxxxxxxxx x nukleotidové xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx, xxxxx xxx XXX xxxxxxx, x.x. | X05XX08 adefovir, J05AF10 xxxxxxxxx |
61 | Xxxxxxxxxx xxxxxxxxxxxxx | 61/1 | xxxxxxxxxx xxxxxxxxxxxxx, x.x. a inhalační xxxxxxxx | X05XX01 zanamivir, J05AH02 xxxxxxxxxxx |
62 | Xxxxxxxxxxxxxx xxxxxxxx xxxxxx | 62/1 | xxxxxxxxxxxxxx xxxxxxxx xxxxxx, x.x. | X06XX01 Xxxxxxxxxxxxxx xxxxxxxx xxxxxx pro xxxxxxxxxxxxxxx xxxxxxxx |
62/2 | xxxxxxxxxxxxxx xxxxxxxx xxxxxx, s.c. | J06BA01 imunoglobuliny xxxxxxxx xxxxxx xxx xxxxxxxxxx aplikaci | ||
62/3 | imunoglobuliny normální xxxxxx, xx. | X06XX02 xxxxxxxxxxxxxx xxxxxxxx xxxxxx pro xxxxxxxxxxxx xxxxxxxx | ||
63 | Xxxxxx | 63/1 | xxxxxx, parenterální | L01CD01 xxxxxxxxxx, X01XX02 docetaxel |
65 | Superaktivní analoga xxxxxxxxxxxx-xxxxxxxxx xxxxxxx | 65/1 | xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxx-xxxxxxxxx hormonu, parenterální | L02AE02 xxxxxxxxxxx, X02XX03 goserelin, L02AE04 xxxxxxxxxxx |
66 | Xxxxxxxxxxxxx x inhibitory xxxxxxxx | 66/1 | xxxxxxxxxxxxx, x.x. | X02XX01 tamoxifen, L02AB02 xxxxxxxxx |
66/2 | xxxxxxxxxx xxxxxxxx, x.x. | X02XX03 xxxxxxxxxx, X02XX04 xxxxxxxx, X02XX06 exemestan | ||
67 | Antiandrogeny | 67/1 | antiandrogeny (xxxxx xxxxxxxxxxxx 150xx), x.x. | X02XX01 xxxxxxxx, X02XX03 xxxxxxxxxxx |
69 | Xxxxxxxxxxx a xxxx léčiva | 69/1 | interferony alfa xxxxxx x xxxxxxx xxxxxxxxx onkologických onemocnění, xxxxxxxxxxxx -xxxxxxxxxxxx formy | L03AB01 xxxxxxxxxx xxxx natural, L03AB04 xxxxxxxxxx xxxx-2x, X03XXX5 interferon xxxx-2x |
69/2 | xxxxxxxxxxx xxxx-2- xxxxxxxxxx xxxxx, xxxxxxxxxxxx | X03XX11 xxxxxxxxxxxxx xxxx-2x, X03XX10 xxxxxxxxxxxxx alfa-2b | ||
69/3 | interferony x xxxxxxx léčiva x terapii roztroušené xxxxxxxx, xxxxxxxxxxxx | X03XXX7 xxxxxxxxxx xxxx-1x, X03XXX8 xxxxxxxxxx beta-1b, L03AX13 xxxxxxxxxx acetat, | ||
70 | Imunosupresiva | 70/1 | imunosupresiva - xXXX inhibitory, x.x. | X04XX10 xxxxxxxxx, X04XX18 everolimus |
70/2 | imunosupresiva - xxxxxxxxxx xxxxxx x xxxxxxx xxxxxxxxxxxx, xxxxxxx xxxx xxxxxxxxx xxxxxxxxxx, parenterální | L04AA11 xxxxxxxxxx, X04XX12 xxxxxxxxxx, X04XX17 xxxxxxxxxx, X04XXX5 xxxxxxxxxxxx-xxxxx X04XXX6 golimumab | ||
70/3 | Imunosupresiva - xxxxxxxxxx léčiva x xxxxxxx xxxxxxxxxxxx, kožních xxxx xxxxxxxxx onemocnění, speciální, xxxxxxxxxxxx | X04XX24 abatacept, L04AC07 xxxxxxxxxxx | ||
71 | Xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx | 71/1 | xxxxxxxxxxx xxxxxxxxxxxxxx xxxxxx - xxxxxxxxxxxx, x.x. | X01XX05 xxxxxxxxxx, X01XX05 xxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX01 xxxxxxxxx, X01XX02 xxxxxxxx, X01XX03 xxxxxxxxxx, X01XX11 xxxxxxxx tiaprofenová, M01AE12 xxxxxxxxx, X01XX17 dexketoprofen, M01AG02 kyselina xxxxxxxxxxx, X01XX01 nabumeton, M01AX17 xxxxxxxxx |
71/2 | xxxxxxxxxxx xxxxxxxxxxxxxx, xxxx. xxxxxxxx | X01XX01 xxxxxxxxxxx, X01XX05 diklofenak, M01AC06 xxxxxxxxx, X01XX01 xxxxxxxxx, X01XX03 xxxxxxxxxx | ||
71/3 | xxxxxxxxxxx xxxxxxxxxxxxxx, xxxxxxxxxxxx | X01XX05 xxxxxxxxxx, X01XX01 piroxikam, M01AC05 xxxxxxxxxx, X01XX06 xxxxxxxxx, X01XX03 ketoprofen, M01AH04 xxxxxxxxx | ||
71/4 | xxxxxxxxxxx protizánětlivá xxxxxx XXX 2 selektivní (xxxxxx), x.x. | X01XX01 xxxxxxxxx, X01XX03 xxxxxxxxxx, X01XX05 xxxxxxxxxx | ||
73 | Xxxxxxxxx působící xxxxxxxxxxxxx | 73/1 | xxxxxxxxx xxxxxxxx myorelaxancia, x.x. | X03XX04 tolperison, M03BX05 xxxxxxxxxxxxxxx, X05XX01 xxxxxxxxxxx, X03XX01 xxxxxxxx, X03XX02 tizanidin, M03BX07 xxxxxxxxxx |
73/2 | xxxxxxxxx xxxxxxxx xxxxxxxxxxxxx, xxxxxxxxxxxx | X03XX04 xxxxxxxxxx, X03XX05 xxxxxxxxxxxxxxx | ||
74 | Xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx | 74/1 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx - xxxxxxx X, x.x. | X11XX01 ergokalciferol, A11CC05 xxxxxxxxxxxxxxx |
74/2 | xxxxxx k terapii x xxxxxxxxx xxxxxxxxxxx - xxxxxxxxxx xxxxxxxx X, x.x. | X11XX03 xxxxxxxxxxxx, X11XX04 xxxxxxxxxx | ||
74/3 | xxxxxx x terapii x xxxxxxxxx xxxxxxxxxxx, x.x. - xxxxxxxxxxxx | X05XX04 xxxxxxxx alendronová, M05BA06 kyselina xxxxxxxxxxx, X05XX07 xxxxxxxx risedronová, M05BB03 xxxxxxxx xxxxxxxxxx x xxx. X3 | ||
74/4 | xxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxxxxx - xxxxxxx xxxxxxxxxxx xxxxxxx x xxxxxxx. xxxxxxxxxxxx | X05XX02 teriparatid, H05AA03 xxxxxxxxxxx | ||
75 | Xxxxxx x xxxxxxx hyperkalcémie x/xxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxxx | 75/1 | xxxxxx k terapii xxxxxxxxxxxxx a/nebo xxxxxxxxx x xxxxxxxxx xxxxxxxxxx, xxxxxxxxxxxx | X05XX02 xxxxxxxx xxxxxxxxxx, X05XX03 xxxxxxxx xxxxxxxxxxx, X05XX06 xxxxxxxx xxxxxxxxxxx, X05XX08 kyselina xxxxxxxxxxx |
76 | Xxxxxxxxxxxxxxxx xxxxxx | 76/1 | xxxxxxxxxxxxxxxx xxxxxx xxx xxxxxxx léčbu xxxxxxxxx xxxxxxxxxxxx xxxxxxx | X01XX02 xxxxxxxx, X01XX04 xxxxxxxxx |
77 | Xxxxxxxxxx xxxxxxx | 77/1 | xxxxxxxxxx xxxxxxx, xxxxxxxxxxxx xxxxxxxx | X01XX xxxxxxxxx, X01XX01 xxxxxxxxxx, X01XX09 xxxxxxxxxx, X01XX10 levobupivakain |
78 | Opioidy | 78/1 | silné xxxxxxx, p.o. | N02AA03 xxxxxxxxxxx, X02XX05 xxxxxxxx |
78/2 | xxxxx xxxxxxx, xxxxxxxxx. xxxxxxxx | X02XX03 fentanyl, N02AE01 buprenorfin | ||
78/3 | slabé xxxxxxx, p.o. | N02AA08 dihydrokodein, N02AX02 xxxxxxxx | ||
78/4 | xxxxx xxxxxxx xxx xxxxx xxxxxxxxx xxxxxxx | X02XX01 xxxxxx, X01XX01 xxxxxxxx | ||
78/5 | xxxxx xxxxxxx xxx xxxxxxxxx, xxxxxxxxxxxx | X01XX01 xxxxxxxx, X01XX02 alfentanyl, N01AH03 xxxxxxxxxx, X01XX06 xxxxxxxxxxxx | ||
79 | Xxxxxxxxxx-xxxxxxxxxxxx | 79/1 | xxxxxxxxxx-xxxxxxxxxxxx, p.o. | N02BA01 xxxxxxxx xxxxxxxxxxxxxxxx, X02XX02 xxxxxxxxx, X02XX01 paracetamol |
79/2 | analgetika-antipyretika, xxxxxxxxxxxx | X02XX02 metamizol, N02BE01 xxxxxxxxxxx | ||
80 | Xxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxx | 80/1 | xxxxxxxxxxxxx k terapii xxxxxxxx xxxxxxxx, p.o. - xxxxxxxxxx xxxxxxxx xxxxxxxxxx | X02XX01 xxxxxxxxxxx, X02XX02 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx, X02XX06 xxxxxxxxxx, X02XX07 xxxxxxxxxxxx |
80/2 | xxxxxxxxxxxxx k terapii xxxxxxxx xxxxxxxx, xxxxx. Xxxxxxxx - xxxxxxxxxx xxxxxxxx xxxxxxxxxx | X02XX01 xxxxxxxxxxx, X02XX03 xxxxxxxxxxxx | ||
82 | Xxxxxxxxxxxxxxxx | 82/1 | xxxxxxxxxxxxxxxx- xxxxxxxxxxxxxxxx, x.x. | X04XX02 xxxxxxxxx, X04XX04 procyklidin, N04AC01 xxxxxxxxxxx |
82/2 | xxxxxxxxxxxxxxxx, xxxxxxxx xxxxxxxx, x.x. | X04XX04 xxxxxxxxx, X04XX05 xxxxxxxxxx | ||
82/3 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXXX, p.o. | N04BX01 xxxxxxxx, X04XX02 xxxxxxxxx | ||
82/4 | xxxxxxxxxxxxxxxx, xxxxxxxxxx XXX, x.x. | X04XX01 selegilin, N04BD02 xxxxxxxxx | ||
83 | Xxxxxxxxxxxxxx - xxxxxxxxxxxx | 83/1 | xxxxxxxxxxxxxx - xxxxxxxxxxxx xxxxxxxx, X xxxxx, x.x. | X05XX01 xxxxxxxxxxxxx, X05XX03 xxxxxxxxxxxxx, X05XX05 zuklopentixol |
83/2 | antipsychotika-neuroleptika xxxxxxxx, II. xxxxx, x.x. | X05XX01 xxxxxxxxxxx, X05XX01 xxxxxxxxxxx | ||
83/3 | xxxxxxxxxxxxxx-xxxxxxxxxxxx, xxxxxxxxxxxx - nedepotní | N05AA01 xxxxxxxxxxxxx, X05XX01 Ievomepromazin, N05AD01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/5 | xxxxxxxxxxxxxx - neuroleptika XX. xxxxx, xxxxxxxxxxxx - depotní | N05AD01 haloperidol, N05AF01 xxxxxxxxxxx, X05XX05 xxxxxxxxxxxxx | ||
83/6 | xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxxxxxxxx potenciálem, x.x. | X05XX03 xxxxxxxx, X05XX03 xxxxxxx | ||
84 | Xxxxxxxxxxxxxx - XX. generace | 84/1 | antipsychotika-antagonisté serotoninových x xxxxxxxxxxxx receptorů | N05AX08 xxxxxxxxxx, X05XX13 paliperidon, N05AE03 xxxxxxxxx, X05XX04 xxxxxxxxxx |
84/2 | xxxxxxxxxxxxxx -xxxxxxxxxxxxxxxx xxxxxxxxxxx | X05XX03 xxxxxxxxx, X05XX04 xxxxxxxxx, X05XX11 xxxxxxx | ||
85 | Xxxxxxxxxxx | 85/1 | xxxxxxxxxxx, x.x. - benzodiazepinová | N05BA01 xxxxxxxx, X05XX02 xxxxxxxxxxxxxxx, X05XX03 medazepam, N05BA04 xxxxxxxx, X05XX08 bromazepam, N05BA12 xxxxxxxxxx, X05XX23 xxxxxxxxx |
86 | Xxxxxxxxxxxxx | 86/1 | xxxxxxxxxxxxx, p.o. - xxxxxxxxxxxx působící inhibitory xxxxxxxx xxxxxxxxx | X06XX02 xxxxxxxxx, X06XX04 xxxxxxxxxxx, X06XX08 dibenzepin, N06AA09 xxxxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX16 xxxxxxxxx, X06XX21 maprotilin, N06AX03 xxxxxxxxx |
86/2 | xxxxxxxxxxxxx, x.x. - xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxx působící xx xxxxx transmiterový xxxxxx (XXXX, NARI, XXXX); - reverzibilní xxxxxxxxxx xxxxxxxxxxxxxxxx (XXXX); - xxxxxxxxx reuptake xxxxxxxxxx (XXX) | X06XX03 xxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX05 xxxxxxxxx, X06XX06 xxxxxxxxx, X06XX08 xxxxxxxxxx, X06XX10 xxxxxxxxxxxx, X06XX05 trazodon, N06AX14 xxxxxxxxx | ||
86/3 | xxxxxxxxxxxxx, x.x. - selektivní xxxxxxxxxx xxxxxxxx monoaminů xxxxxxxx xx dva xxxxxxxxxxxxx xxxxxxx (XXXX, XxXXX, XXXX) | X06XX16 xxxxxxxxxx, X06XX17 xxxxxxxxxxx, X06XX11 mirtazapin | ||
87 | Léčiva x xxxxxxx xxxxxxx Alzheimerova xxxx | 87/1 | xxxxxx x xxxxxxx Xxxxxxxxxxxx choroby, x.x. a xxxxxxxxxxxxx xxxxxxxx | X06XX02 xxxxxxxxx, X06XX03 xxxxxxxxxxx, X06XX04 xxxxxxxxxx, X06XX01 xxxxxxxx |
88 | Xxxxxxxxxx | 88/2 | xxxxxxxxxx, parenterální | N06BX03 xxxxxxxxx, X06XX18 xxxxxxxxxx |
89 | Xxxxxxxxxxxxxx xxxxx | 89/1 | xxxxxxxxxxxxxxxxxxx, x.x. (xxxxx distigminu) | N07AA01 xxxxxxxxxx, X07XX30 xxxxxxxxxx |
90 | Xxxxxx x xxxxxxx xxxxxxx a xxxxxxxxx xxxxxxxxx xxxxxxxxx | 90/1 | xxxxxx xxxxxxxxx x xxxxxxx terapii x xxxxxxxxx xxxxxxxxx rhinitidy - xxxxxxxxxxxxxxx intranasalní xxxxxxxx | X01XX01 xxxxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX06 xxxxxxxxx, X01XX08 flutikason, R01AD12 xxxxxxxxxx-xx xxxx |
90/2 | xxxxxx používaná k lokální xxxxxxx x profylaxi xxxxxxxxx rhinitidy - xxxxxxxxxxxxxxx xxxxxxxxxxxx xxxxxxxx | X01XX02 xxxxxxxxxxxx, X01XX03 azelastin | ||
91 | Úlevová xxxxxx x terapii xxxxxxx | 91/1 | xxxxxx xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, x.x. | X030002 xxxxxxxxxx, X030008 xxxxxxxxxx, X03XX13 klenbuterol |
91/2 | léčiva xxxxxxxxx x xxxxxxx xxxxxxx xxxxxxx, xxxxxxxxx xxxxxxxx | X03XX02 salbutamol, R03AC03 xxxxxxxxxx, X03XX04 xxxxxxxxx | ||
92 | Xxxxxxxxxxx antiastmatika- xxxxxxxxxxxxxxx | 92/1 | xxxxxxxxxxx xxxxxxxxxxxxx - xxxxxxxxxxxxxxx, xx xxxxx xxxxxxxx, xxxxxxxx x xxxxxxx x xxxxxxxxx xxxxxxxx | X03XX02 xxxxxxxxx, X03XX05 xxxxxxxxxx, X03XX08 xxxxxxxxxx |
92/2 | xxxxxxxxxxx xxxxxxxxxxxxx - kortikosteroidy, prášky, xxxxxxxxx xxxxxxxx | X03XX02 xxxxxxxxx, X03XX05 xxxxxxxxxx | ||
93 | Xxxxxxxxxxx xxxxxxxxxxxxx | 93/1 | xxxxxxxxxxx xxxxxxxxxxxxx xx xxxxxxx xxxxxxxxxx xxxxxxxx betamimetika, xxxxxxxxx xxxxxxxx | X03XX12 salmeterol, R03AC13 xxxxxxxxxx |
93/2 | xxxxxxxxxxx xxxxxxxxxxxxx, x.x. - xxxxxxx | X03XX04 teofylin (xxxxxxxxxxx xxxxxx formy), R03DA05 aminofylin (xxxxxxxxxxx xxxxxx xxxxx) | ||
93/3 | xxxxxxxxxxx xxxxxxxxxxxxx, p.o. - xxxxxxxxxxxxxxx | X03XX01 zafirlukast, R03DC03 xxxxxxxxxxx | ||
94 | Xxxxxxxxxxxxx | 94/2 | xxxxxxxxxxxxx, xxxxxxxxxxxx x xxxxxxxxx xxxxxxxx | X05XX01 xxxxxxxxxxxxx, X05XX02 xxxxxxxxx, XX5XX03 xxxxxxxxxxxx, X05XX05 mesna, R05CB06 xxxxxxxx |
95 | Xxxxxxxxxx | 95/1 | xxxxxxxxxx, x.x. (xxxxx kodeinu) | R05DA01 xxxxxxxxxxx, X05XX13 xxxxxxxxx, X05XX19 xxxxxxxxxxx, X05XX27 xxxxxxxxxxxxxxx |
96 | Xxxxxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxx | 96/1 | xxxxxxxxxxxxxxx sedativní, x.x. | X06XX04 xxxxxxxxx, X06XX03 xxxxxxxxxx, X06XX xxxxxxxxx, X06XX02 xxxxxxxxxxxxx, XX06XX17 xxxxxxxxx |
96/2 | xxxxxxxxxxxxxxx xxxxxxxxxxx, x.x. | X06XX07 cetirizin, R06AE09 xxxxxxxxxxxxx, X06XX13 xxxxxxxxx, X06XX26 fexofenadin, R06AX27 xxxxxxxxxxxx, X06XX29 xxxxxxxx | ||
97 | Xxxxxxxxxxxxx - xxxxxxxxxxxxx | 97/1 | xxxxxxxxxxxxx, xxxxxxxxxxxxx - xxxxxxxxx, xxxxxxx | X01XX11 xxxxxxxxx, X01XX13 ci xxxxxxxxxx n, S0lAX17 xxxxxxxxxxxx, X01XX19 xxxxxxxxxxxx, X0xXX22 xxxxxxxxxxxx |
97/2 | xxxxxxxxxxxxx, xxxxxxxxxxxxx - xxxxxxxxxxx xxxxxxx, xxxxxxx | X01XX01 chloramfenikol, S01AA11 xxxxxxxxxx, X01XX12 xxxxxxxxxx, X01XX13 xxxxxx xxxxxxxxx, X01XX23 xxxxxxxxxx X01XX24 kanamycin, S01AA30 xxxxxxxxx xxxxxxx antibiotik - xxxxxxxx/xxxxxxxxxx, X01XX04 sulfacetamid | ||
97/3 | oftalmologika - xxxxxxxxxxxxx - virostatika, xxxxxxx | X01XX03 xxxxxxxxx, X01XX09 xxxxxxxxxxx | ||
98 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxxx | 98/1 | xxxxxxxxxxxxx - xxxxxxxxxxxxxxx xxxx xxxx, xxxxxxx | X01XX01 dexamethason, S01BA02 hydrokortison |
98/2 | oftalmologika - xxxxxxxxxxxxxxx druhé xxxx, xxxxxxx | X01XX03 xxxxxxxx, X01XX04 xxxxxxxxxxx, X01XX07 xxxxxxxxxxxxxx | ||
99 | Xxxxxxxxxxxxx - xxxxxxxxxxxxxx léčiva | 99/1 | oftalmologika - xxxxxxxxxxxxxx léčiva, lokální | S01BC01 xxxxxxxxxxx, X01XX03 xxxxxxxxxx |
100 | Xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx | 100/1 | xxxxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxxxxxx, lokální | S01EA04 xxxxxxxx, X01XX05 xxxxxxxxxx, X01XX01 xxxxxxxxxx |
100/2 | xxxxxxxxxxxxx xxxxxxxxx | X01XX03 xxxxxxxxxx, | ||
x xxxxxxx xxxxxxxx - xxxxxxxxxx xxxxxxxxxxxxxx, xxxxxxx | X01XX04 xxxxxxxxxxx | |||
100/3 | xxxxxxxxxxxxx x xxxxxxx xxxxxxxx - xxxxxxxxxxxxx, lokální | S01ED01 xxxxxxx, X01XX02 xxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX05 karteolol | ||
100/4 | oftalmologika xxxxxxxxx x terapii xxxxxxxx - prostaglandiny xxxx xxxxxx deriváty, xxxxxxx | X01XX01 latanoprost, S01EE02 xxxxxxxxxx, X01XX03 xxxxxxxxxxx, X01XX04 travoprost, S01EE05 tafluprost | ||
101 | Ophtalmologika - xxxxxxx | 101/1 | xxxxxxxxxxxxxx - xxxxxx | X01XX xxxxx draselný+sodný, X01XX04 xxxxx xxxxxxxx |
102 | Xxxxxxxxxxxxx - xxxxxxxxxxxx (xxxxx xxxxxxxxxxxxxxx) | 102/1 | xxxxxxxxxxxxx - xxxxxxxxxxxx | X01XX52 xxxxxxxxxx xxxxxxxxx, X01XX01 kyselina xxxxxxxxxxxx, X01XX02 xxxxxxxxxxxx, X01XX03 kyselina xxxxxxxxxx, X01XX05 xxxxxxxxx, X01XX06 emedastin, S01GX07 xxxxxxxx, X01XX08 xxxxxxxxx, X01XX09 olopatadin, S01GX10 xxxxxxxxx |
103 | Xxxxxxxxxx anti- VEGF x xxxxxxxxxxxx | 103/1 | xxxxxxxxxx anti-VEGF x xxxxxxxxxxxx | X01XX03 xxxxxxxxxx, X01XX04 xxxxxxxxxxx |
104 | Xxxxxxxxxxxx extrakty xxxxxxxx | 104/2 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx | X01XX xxxxxxxx xxxxxxxx |
104/3 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx, xxxxxxxxxx, sublinguální | V01AA xxxxxxxx xxxxxxxx | ||
104/6 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx, injekční, xxxxx | X01XX xxxxxxxx xxxxxxxx | ||
104/7 | xxxxxxxxxxxx xxxxxxxx xxxxxxxx - xxxxxxxxxxxxxxx, injekční, xxxxxxx | X01XX xxxxxxxx xxxxxxxx | ||
105 | Xxxxx xxx xxxxxxxxx xxxxxxx | 105/1 | xxxxx pro xxxxxxxxx xxxxxxx - xxxxxxxxxxxxx | X04XX xxxxx xxx xxxxxxxxx choroby |
105/2 | testy xxx xxxxxxxxx xxxxxxx - xxxxx testy | V04CL xxxxx xxx alergické choroby | ||
106 | Léčiva xxxxxxxxx k terapii xxxxxxxxxxxx x hyperfosfatemie | 106/1 | léčiva x xxxxxxx xxxxxxxxxxxx a xxxxxxxxxxxxxxx, x.x. | X03XX02 xxxxxxxxx, X03XX03 xxxxxxxxxxxxxxx |
107 | Xxxxxx pro xxxxxxx xxxxxxx xxxxxxxxxxx | 107/1 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx (xxxxxxxx formy na xxxxx xxxxxxxxxxxx) | X06XX1 |
107/2 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx fenylalaninu x xxxxxxx sacharidů x xxxx pro xxxxxxxx xx 1 xxxx xxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX2 | ||
107/3 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxxxx xxx těhotné (xxxxxxxx formy xx xxxxx aminokyselin) | V06CA4 | ||
107/4 | definované xxxxx xxxxxxxxxxxx xxx fenylalaninu (xxxxxxxxx xxxxx xx xxxxx aminokyselin) | V06CA5 | ||
107/5 | definované xxxxx xxxxxxxxxxxx xxx fenylalaninu (xxxxxxxxx formy xxxxxx xx xxxxx aminokyselin) | V06DD11 | ||
107/6 | definované xxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxxxx xx 1 roku xxxx x xxxxxxxx xxxxxxxxxxx xxxxx močoviny (xxxxxxxx xxxxx na xxxxx xxxxxxxxxxxx) | X06XX12 | ||
107/7 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxx xxx pacienty xxx 1 rok xxxx x xxxxxxxx metabolismu xxxxx xxxxxxxx (xxxxxxxx xxxxx na xxxxx xxxxxxxxxxxx) | X06XX13 | ||
107/8 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx se xxxxxxxxx a xxxx xxx xxxxxxxx xx 1 roku věku - kompletní xxxxxxxxx xxxxxx (práškové formy xx xxxxx xxxxxxxxxxxx) | X06XX14 | ||
107/9 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxx x xxxxxx xxx pacienty xx 1 xxxx xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | V06DD15 | ||
107/10 | definované xxxxx aminokyselin xxx xxxxxxxxxx, leucinu x xxxxxx xxx xxxxxxxx xxx 1 xxx xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | V06DD16 | ||
107/11 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx, xxxxxxxxxx, threoninu x valinu pro xxxxxxxx x xxxxxxxxxxxxxx x xxxxxxxxxxx xxxxxxxx xx 1 roku xxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX17 | ||
107/12 | xxxxxxxxxx xxxxx aminokyselin bez xxxxxxxxxx, methioninu, xxxxxxxxx x valinu xxx xxxxxxxx x xxxxxxxxxxxxxx x xxxxxxxxxxx xxxxxxxx xxx 1 rok xxxx (práškové xxxxx xx xxxxx aminokyselin) | V06DD18 | ||
107/13 | definované xxxxx aminokyselin xxx xxxxxxx xxx xxxxxxxx xx 1 roku xxxx (práškové formy xx xxxxx xxxxxxxxxxxx) | X06XX19 | ||
107/14 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxx pro pacienty xxx 1 rok xxxx (xxxxxxxx xxxxx xx obsah aminokyselin) | V06DD20 | ||
107/15 | definované xxxxx xxxxxxxxxxxx xxx xxxxxx x se xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx xxxxxxxx s glutarovou xxxxxxxx xx 1 xxxx věku (xxxxxxxx xxxxx na obsah xxxxxxxxxxxx) | X06XX21 | ||
107/16 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx lysinu x xx xxxxxxxx xxxxxxxxx xxxxxxxxxx xxx pacienty x glatarovou xxxxxxxx xxx 1 xxx xxxx (práškové xxxxx xx obsah aminokyselin) | V06DD22 | ||
107/17 | definované xxxxx xxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxx X-xxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxxxx do 1 xxxx věku (xxxxxxxx xxxxx na xxxxx xxxxxxxxxxxx) | X06XX23 | ||
107/18 | xxxxxxxxxx směsi xxxxxxxxxxxx xxx xxxxxxxxxx xxxxxxxxx X-xxxxxxx xxx xxxxxxxx x xxxxxxxxxxxxxx xxx 1 xxx xxxx (xxxxxxxx xxxxx xx obsah xxxxxxxxxxxx) | X06XX26 | ||
107/19 | xxxxxxxxxx směsi aminokyselin xxx xxxxxxxx x xxxxxxxxxxxx xx xxxxxxxxx x xxxx pro xxxxxxxx do 1 xxxx xxxx - xxxxxxxxx xxxxxxxxx xxxxxx (xxxxxxxx formy xx xxxxx xxxxxxxxxxxx) | X06XX27 | ||
107/20 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx xxx xxxxxxxx xx 1 xxxx xxxx (xxxxxxxx xxxxx xx xxxxx xxxxxxxxxxxx) | X06XX29 | ||
107/21 | xxxxxxxxxx xxxxx xxxxxxxxxxxx xxx xxxxxxxx x xxxxxxxxxxxx pro xxxxxxxx xxx 1 xxx xxxx (xxxxxxxx xxxxx xx xxxxx aminokyselin) | V06DD27 | ||
107/22 | definované xxxxx aminokyselin xxxxxx xxxxxxxxx s peptidy x xxxxxx xxxxxxx fenylalaninu (xxxxxxxx xxxxx xx xxxxx aminokyselin) | V06DD29 | ||
108 | Výživy-enterální xxxxxx | 108/1 | xxxxxxxxx xxxxxx standardní - x xxxxxx xxxxx | X06XX1 |
108/2 | xxxxxxxxx xxxxxx xxxxxxxxxx - hyperkalorická | V06EB01 | ||
108/3 | polymerní xxxxxx xxxxxxxxxx - x xxxxxxxx xxxxxxxx xxxxxxxxxxxx | X06XX02, X06XX04 | ||
108/4 | xxxxxxxxx xxxxxx xxxxxxxxxx - x xxxxxxxx vlákniny hyperkalorická | V06EB02, V06EB04 | ||
108/5 | polymerní xxxxxx xxxxxxxxx - xxxxxxxxxxxxxx xxx xxxx | X06XX03 | ||
108/6 | xxxxxxxxx xxxxxx xxxxxxxxx – xxxxxxxxxxxxxx s doplňkem xxxxxxxx xxxxx xxxxxxxx x vlákniny | V06EB05, V06EB06 | ||
108/7 | polymerní xxxxxx xxxxxxxxx - xxxxxx xxx xxxxx xxxxxxxxx xxxxxxx | X06XX10 | ||
108/8 | xxxxxxxxx výživa xxxxxxxxx - x doplňkem xxxxxxxx, xxxxxxxx x xxxxx | X06XX11 | ||
108/10 | xxxxxxxxx xxxxxx xxxxxxxxx - xxxxxxxxxx | X06XX08 | ||
108/11 | xxxxxxxxx xxxxxx xxxxxxxxx - x xxxxxxxx MCT olejů | V06EB09 | ||
108/12 | oligopeptidická xxxxxx xxxxxx | X06XX1 | ||
108/13 | xxxxxx'xxxxxx | X06XX1 | ||
109 | xxxxxx- xxxxxxx xxxxx | 109/1 | xxxxxxx xxxxx s obsahem xxxxxxxxx xxxxxxxxx xxxxx | X06XX1 |
109/2 | xxxxxxx xxxxx x xxxxxxx proteinovým xxxxxxxxxxxx | X06XX2 | ||
109/3 | xxxxxxx mléka x xxxxxx xxxxxxx xxxxxxx x xxxxxxx xxxxxxxxxxx h xx xx X xxxxx m | V06DF4 | ||
109/4 | speciální xxxxxxxxx xxxxxx s xxxxxxx xxxxxxxxxxxx aminokyselin | V06DE | ||
110 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx- xxxxxxxxxx Zátky- xxxxxxxxx | 110/1 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 150 mg/mi, xxxxxxxxxxxx | XX8XX09 iodixanol, V08AB10 xxxxxxxx |
110/2 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - xxxxxxxxxxx xxxx 200 xx/xx, xxxxxxxxxxxx | XX8XX04 xxxxxxxxx, X08XX10 iomeprol | ||
110/3 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx látky - xxxxxxxxx - xxxxxxxxxxx xxxx 240 xx/xx, xxxxxxxxxxxx | X08XX02 xxxxxxx, X08XX05 iopromid, V0BAB07 xxxxxxxx | ||
110/4 | XXX xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx xxxx 300 xx/xx, parenterální | V08AB02 iohexol, V08AB04 xxxxxxxxx, X08XX05 xxxxxxxx, X08XX07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 iobitrodol | ||
110/5 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx nefrotropní xxx-xxxxxxxxxx xxxxx - neionické - xxxxxxxxxxx jodu 320 xx/xx, xxxxxxxxxxxx | X08XX03 xxxxxxxx ioxagliková, V08AB07 ioversol, V08AB09 xxxxxxxxx | ||
110/6 | XXX vodorozpustné xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx látky - neionické - xxxxxxxxxxx xxxx 350 xx/xx, parenterální | V08AB02 iohexol, V08AB07 xxxxxxxx, X08XX10 xxxxxxxx, X08XX11 iobitridol | ||
110/7 | RTG xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxx-xxxxxxxxxx xxxxx - xxxxxxxxx - koncentrace xxxx 370 mg/ml, xxxxxxxxxxxx | X08XX04 xxxxxxxxx, X08XX05 xxxxxxxx | ||
111 | Xxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxxxx | 111/1 | xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxxxxx, xxxxxxxxxxxx | X08XX01 xxxxxxxxxxxx x xxxxxxxxx, X08XX05 xxxxxx xxxxxxxxxxx |
114 | Xxxxxxxxxxxxxx látky | 114/1 | paramagnetické xxxxx x xxxxxxx xxxxxxxxx | X08XX01 xxxxxxxx xxxxxxxxxxxxx, X08XX02 xxxxxxxx gadoterová, V08CA03 gadodiamid, V08CA04 xxxxxxxxxxx |
Xx. XX
Xxxxxxxx
Tato vyhláška xxxxxx xxxxxxxxx xxxx 1. ledna 2012.
Ministr:
xxx. XXXx. Xxxxx, XXx., x. r.
Informace
Xxxxxx xxxxxxx x. 386/2011 Sb. xxxxx xxxxxxxxx dnem 1.1.2012.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem jiných xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.